|
![]() |
|||
|
||||
OverviewRecombinant Poxviruses provides a comprehensive examination of poxviruses with an emphasis on the potential of these viruses as new vaccines. The book considers a wide range of issues involved in producing new genetically engineered live vaccines, such as efficacy, safety, stability, cost, host range, immune response, immunization route, use of multivalent vaccines, and need for revaccination. The opening chapter describes the origin of vaccinia virus, its use to eradicate smallpox, and the pathogenesis of poxvirus infections. Subsequent chapters examine the molecular biology of poxviruses, methods of constructing vaccinia virus recombinants, and applications; the use and immune responses induced by poxvirus recombinants as live vaccines; and the important issues of the safety and immunogenicity of vaccinia virus. The book's final two chapters report the progress that has been made developing avipoxviruses and parapoxviruses as candidate recombinant vaccines. Recombinant Poxviruses will be a welcome addition to the bookshelves of virologists, microbiologists, infectious disease specialists, and veterinarians. Full Product DetailsAuthor: Matthew M. Binns , Geoffrey L. Smith , Geoffrey L. Smith (University of Cambridge Cambridge University Cambridge University University of Cambridge Cambridge University) , M. AubertPublisher: Taylor & Francis Inc Imprint: CRC Press Inc Weight: 0.725kg ISBN: 9780849361791ISBN 10: 0849361796 Pages: 368 Publication Date: 27 May 1992 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationMatthew M. Binns, Geoffrey L. Smith Tab Content 6Author Website:Countries AvailableAll regions |